Clinical Trial Update: Low Dose Naltrexone for Chronic Pain From Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of low-dose naltrexone for chronic pain from arthritis has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis Psoriatic
• Arthritis Rheumatoid
• Osteoarthritis

Drugs mentioned

• Low Dose Naltrexone (naltrexone)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Osteoarthritis, Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2021-03-03